Aristocort and Atarax drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aristocort (triamcinolone) and Atarax (hydroxyzine hydrochloride). Common drug interactions include migraine among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Aristocort and Atarax. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Aristocort?

Aristocort has active ingredients of triamcinolone. eHealthMe is studying from 508 Aristocort users. Check the latest studies of Aristocort.

What is Atarax?

Atarax has active ingredients of hydroxyzine hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 23,553 Atarax users. Check the latest studies of Atarax.

On Jul, 14, 2026

36 people who take Aristocort and Atarax together, and have interactions are studied.

Aristocort and Atarax drug interactions.

What are the common drug interactions of Aristocort and Atarax, by gender? *:

female:

Migraine (headache)
Nasopharyngitis (inflammation of the nasopharynx)
Pain of skin
Psoriasis (immune-mediated disease that affects the skin)
Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
Rales (an abnormal respiratory sound characterized by fine crackles)
Rash erythematous (redness of the skin)
Respiratory tract congestion (blockage on respiratory system)
Respiratory tract infection
Sinusitis (inflammation of sinus)

male:

Fatigue (feeling of tiredness)
Weight decreased
Activities of daily living impaired
Hospitalisation
Hypersensitivity
Autonomic nervous system imbalance (autonomic nervous system is of net equal emphasis)
Dyspnoea (difficult or laboured respiration)
Alopecia (absence of hair from areas of the body)
Blood pressure increased
Disturbance in attention

What are the common drug interactions of Aristocort and Atarax, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Arthritis (form of joint disorder that involves inflammation of one or more joints)
Dyspnoea (difficult or laboured respiration)
Erythema (redness of the skin)
Nausea (feeling of having an urge to vomit)
Pain
Pyrexia (fever)
Weight decreased
Abdominal discomfort
Blood pressure systolic increased
Cough

50-59:

Retroperitoneal mass (mass between peritoneum and the posterior abdominal wall)
Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
Sputum discoloured
Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
Syncope (loss of consciousness with an inability to maintain postural tone)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Tricuspid valve incompetence (inefficient heart valve)
Upper respiratory tract infection
Viral infection
Vomiting

60+:

Fatigue (feeling of tiredness)
Weight decreased
Autonomic nervous system imbalance (autonomic nervous system is of net equal emphasis)
Rash
Blood pressure increased
Dyspnoea (difficult or laboured respiration)
Alopecia (absence of hair from areas of the body)
Anaemia (lack of blood)
Disturbance in attention
Drug ineffective

What are the existing conditions these people have? *

Burkitt Lymphoma (cancer of the lymphatic system): 9 people, 25.00%
Itching: 9 people, 25.00%
Asthma: 4 people, 11.11%
Nausea And Vomiting: 3 people, 8.33%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 8.33%
Diarrhea: 3 people, 8.33%
Drowsiness: 3 people, 8.33%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 8.33%
Nausea (feeling of having an urge to vomit): 3 people, 8.33%
Oesophageal Disorder (disease of oesophagus): 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Aristocort and Atarax?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously